CORE LABORATORIES N.V. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2022-11-04: Form 8-K; Period of report 2022-11-04; Description 8.01 Other Events; Details 8.01.
- 2022-10-26: Form 8-K; Period of report 2022-10-26; Description 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; Details 2.02.
- 2022-07-27: Form 8-K; Period of report 2022-07-27; Description 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; Details 2.02.
- 2022-07-27: Form 8-K; Period of report 2022-07-25; Description 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Details 1.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2022-11-04 | 8-K | 2022-11-04 | 8.01 Other Events | 8.01 On November 4, 2022, Core Laboratories N.V. issued a press release announcing its decision to proceed with the voluntary delisting of its shares from Euronext Amsterdam. | clb-20221104.htm |
| 2022-10-26 | 8-K | 2022-10-26 | 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure | 2.02 On October 26, 2022, Core Laboratories N.V. issued a press release announcing its financial results for the third quarter of 2022. 7.01 On October 26, 2022, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.01 per share of common stock for shareholders of record on November 7, 2022 and payable November 28, 2022. | clb-20221026.htm |
| 2022-07-27 | 8-K | 2022-07-27 | 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure | 2.02 On July 27, 2022, Core Laboratories N.V. (the “Company”) issued a press release announcing its financial results for the second quarter of 2022. 7.01 On July 27, 2022, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.01 per share of common stock for shareholders of record on August 8, 2022 and payable August 29, 2022. | clb-20220727.htm |
| 2022-07-27 | 8-K | 2022-07-25 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.01 Entry into a Material Definitive Agreement. | clb-20220725.htm |
| 2022-06-09 | 8-K | 2022-06-09 | 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 8.01 On June 9, 2022, the Company issued a press release announcing the establishment of an “at-the-market” equity offering program. | d326331d8k.htm |
| 2022-06-08 | 8-K | 2022-06-08 | 8.01 Other Events | 8.01 We depend on the results of our international operations, which expose us to risks inherent in doing business abroad. | clb-20220608.htm |
| 2022-05-19 | 8-K | 2022-05-19 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 Core Laboratories N.V. (the "Company") held its Annual Meeting of Shareholders (the "Annual Meeting") on May 19, 2022 in Amsterdam, the Netherlands. | clb-20220519.htm |
| 2022-04-27 | 8-K | 2022-04-27 | 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure | 2.02 On April 27, 2022, Core Laboratories N.V. (the “Company”) issued a press release announcing its financial results for the first quarter of 2022. 7.01 On April 27, 2022, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.01 per share of common stock for shareholders of record on May 9, 2022 and payable May 31, 2022. | clb-20220427.htm |
| 2022-03-16 | 8-K | 2022-03-16 | 7.01 Regulation FD Disclosure | 7.01 On March 16, 2022, Core Laboratories N.V. issued a press release announcing revisions to previously issued earnings guidance for its 2022 first quarter. | clb-20220316.htm |
| 2022-02-02 | 8-K | 2022-02-02 | 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure | 2.02 On February 2, 2022, Core Laboratories N.V. (the “Company”) issued a press release announcing its financial results for the fourth quarter of 2021 and year ending December 31, 2021. 7.01 On February 2, 2022, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.01 per share of common stock for shareholders of record on February 14, 2022 and payable March 7, 2022. | clb-20220202.htm |